NCT00237380View on ClinicalTrials.gov

Safety and Efficacy of Ataluren (PTC124) for Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Cystic Fibrosis

Interventions

DRUG

Ataluren

Ataluren will be provided as a vanilla-flavored powder to be mixed with water.

Trial Locations (1)

91240

Hadassah University Hospital - Mount Scopus, Jerusalem

Sponsors

Lead Sponsor

PTC Therapeutics

All Listed Sponsors

lead

PTC Therapeutics

INDUSTRY